Jesper Falkesgaard Højen

Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.

Jesper Damsgaard Gunst, Marie H. Pahus, Lena Hagelskjær Kristensen et al. · EClinicalMedicine · 2021 · 192 citations · Full text

Controlled Trial, Covid-19 Pandemic, Clinical Trials +6

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

Steffen Leth, Mariane Høgsbjerg Schleimann, Sara Konstantin Nissen et al. · The Lancet HIV · 2016 · 173 citations

Vaccination, Granulocyte, Human Retrovirus +9

SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

Line K. Vibholm, Stine Sofie Frank Nielsen, Marie H. Pahus et al. · EBioMedicine · 2021 · 166 citations · Full text

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

Line K. Vibholm, Mariane Høgsbjerg Schleimann, Jesper Falkesgaard Højen et al. · Clinical Infectious Diseases · 2017 · 143 citations · Full text

SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

Stine Sofie Frank Nielsen, Line K. Vibholm, Ida Monrad et al. · EBioMedicine · 2021 · 84 citations · Full text